Changchuin Mao

728 total citations
20 papers, 573 citations indexed

About

Changchuin Mao is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Changchuin Mao has authored 20 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 8 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Molecular Biology. Recurrent topics in Changchuin Mao's work include Monoclonal and Polyclonal Antibodies Research (8 papers), T-cell and B-cell Immunology (7 papers) and Immune Cell Function and Interaction (6 papers). Changchuin Mao is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), T-cell and B-cell Immunology (7 papers) and Immune Cell Function and Interaction (6 papers). Changchuin Mao collaborates with scholars based in United States, China and Greece. Changchuin Mao's co-authors include Ajay Singh, Serge Lemay, Fotini Gounari, Marei Dose, Philip N. Tsichlis, Philip W. Hinds, Amit Deshpande, Miaofen G. Hu, Guo‐fu Hu and Michael C. Carroll and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Blood.

In The Last Decade

Changchuin Mao

20 papers receiving 568 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changchuin Mao United States 11 303 217 165 71 54 20 573
Stéphane Bécart United States 16 387 1.3× 182 0.8× 155 0.9× 71 1.0× 20 0.4× 21 588
Paola Pittoni Italy 12 571 1.9× 125 0.6× 170 1.0× 58 0.8× 51 0.9× 13 689
S. M. Shahjahan Miah United States 18 393 1.3× 267 1.2× 128 0.8× 70 1.0× 15 0.3× 23 665
Noriyasu Seki Japan 13 407 1.3× 206 0.9× 163 1.0× 113 1.6× 86 1.6× 26 693
Patricia Marchal France 8 179 0.6× 212 1.0× 89 0.5× 60 0.8× 26 0.5× 11 462
Dávid Győri Hungary 11 228 0.8× 244 1.1× 227 1.4× 46 0.6× 45 0.8× 16 526
Alexander Martens Germany 14 530 1.7× 181 0.8× 503 3.0× 37 0.5× 46 0.9× 22 787
Tammy P. Cheng United States 12 284 0.9× 135 0.6× 111 0.7× 63 0.9× 14 0.3× 12 521
Cyril Šálek Czechia 14 311 1.0× 243 1.1× 275 1.7× 37 0.5× 41 0.8× 47 728
Xingwen Dong United States 9 224 0.7× 266 1.2× 83 0.5× 72 1.0× 12 0.2× 15 528

Countries citing papers authored by Changchuin Mao

Since Specialization
Citations

This map shows the geographic impact of Changchuin Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changchuin Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changchuin Mao more than expected).

Fields of papers citing papers by Changchuin Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changchuin Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changchuin Mao. The network helps show where Changchuin Mao may publish in the future.

Co-authorship network of co-authors of Changchuin Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Changchuin Mao. A scholar is included among the top collaborators of Changchuin Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changchuin Mao. Changchuin Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mao, Changchuin, Karen Eberle, Xiaojie Chen, et al.. (2024). FcRider: a recombinant Fc nanoparticle with endogenous adjuvant activities for hybrid immunization. PubMed. 7(4). 295–306. 1 indexed citations
2.
Mao, Changchuin, Jun Li, Lili Feng, & Wenda Gao. (2023). Beyond antibody fucosylation: α-(1,6)-fucosyltransferase (Fut8) as a potential new therapeutic target for cancer immunotherapy. PubMed. 6(2). 87–96. 10 indexed citations
3.
Zhang, Haohai, Lili Feng, Paola de Andrade Mello, et al.. (2022). Glycoengineered anti-CD39 promotes anticancer responses by depleting suppressive cells and inhibiting angiogenesis in tumor models. Journal of Clinical Investigation. 132(13). 20 indexed citations
4.
Wang, Qiao, Lili Feng, Haohai Zhang, et al.. (2022). Longitudinal waning of mRNA vaccine-induced neutralizing antibodies against SARS-CoV-2 detected by an LFIA rapid test. PubMed. 5(1). 55–62. 5 indexed citations
5.
Yan, Jun, Jing Yu, Ke Liu, et al.. (2021). The Pathogenic Roles of IL-22 in Colitis: Its Transcription Regulation by Musculin in T Helper Subsets and Innate Lymphoid Cells. Frontiers in Immunology. 12. 758730–758730. 19 indexed citations
6.
Mao, Changchuin, Esther Landesman‐Bollag, Ángel Rubio, et al.. (2021). L2pB1 Cells Contribute to Tumor Growth Inhibition. Frontiers in Immunology. 12. 722451–722451. 4 indexed citations
7.
Mao, Changchuin, Richard I. Near, Xuemei Zhong, & Wenda Gao. (2021). Cross-species higher sensitivities of FcγRIIIA/FcγRIV to afucosylated IgG for enhanced ADCC. PubMed. 4(3). 159–170. 4 indexed citations
8.
Mao, Changchuin, et al.. (2020). An IgA mimicry of IgG that binds polymeric immunoglobulin receptor for mucosa transcytosis. PubMed. 3(3). 157–162. 3 indexed citations
9.
Mao, Changchuin, Richard I. Near, & Wenda Gao. (2017). Identification of a Guinea Pig Fcγ Receptor that Exhibits Enhanced Binding to Afucosylated Human and Mouse IgG. PubMed. 1(1). 3 indexed citations
10.
Mao, Changchuin, et al.. (2015). Fluorescence tagging and inducible depletion of PD‐L2–expressing B‐1 B cells in vivo. Annals of the New York Academy of Sciences. 1362(1). 77–85. 7 indexed citations
11.
Chiu, Joanna C., Changchuin Mao, Yaqi Wang, et al.. (2014). High fat diet deviates PtC‐specific B1 B cell phagocytosis in obese mice. Immunity Inflammation and Disease. 2(4). 254–261. 8 indexed citations
12.
Serebrennikova, Oksana B., Christos Tsatsanis, Changchuin Mao, et al.. (2012). Tpl2ablation promotes intestinal inflammation and tumorigenesis inApcminmice by inhibiting IL-10 secretion and regulatory T-cell generation. Proceedings of the National Academy of Sciences. 109(18). E1082–91. 44 indexed citations
13.
Hu, Miaofen G., Amit Deshpande, Changchuin Mao, et al.. (2011). CDK6 kinase activity is required for thymocyte development. Blood. 117(23). 6120–6131. 61 indexed citations
14.
Hu, Miaofen G., Amit Deshpande, Miriam Enos, et al.. (2009). A Requirement for Cyclin-Dependent Kinase 6 in Thymocyte Development and Tumorigenesis. Cancer Research. 69(3). 810–818. 96 indexed citations
15.
Mao, Changchuin, Esmerina Tili, Marei Dose, et al.. (2007). Unequal Contribution of Akt Isoforms in the Double-Negative to Double-Positive Thymocyte Transition. The Journal of Immunology. 178(9). 5443–5453. 85 indexed citations
16.
Mao, Changchuin, et al.. (2004). T Cell-Independent Somatic Hypermutation in Murine B Cells with an Immature Phenotype. Immunity. 20(2). 133–144. 87 indexed citations
17.
Lemay, Serge, Changchuin Mao, & Ajay Singh. (1996). Cytokine gene expression in the MRL/lpr model of lupus nephritis. Kidney International. 50(1). 85–93. 75 indexed citations
18.
Mao, Changchuin & Ajay Singh. (1996). IL-lβ Gene Expression in B Cells Derived from the Murine MRL/lpr Model of Lupus. Autoimmunity. 24(2). 71–79. 7 indexed citations
19.
Singh, Ajay, Changchuin Mao, & Tatiana Lebedeva. (1994). In Vitro Role of IL-1 in Heightened IgG, Anti-DNA, and Nephritogenic Idiotype Production by B Cells Derived from the Murine MRL/lpr Lupus Model. Clinical Immunology and Immunopathology. 72(3). 410–415. 13 indexed citations
20.
Rajagopalan, Sumati, Changchuin Mao, & Syamal K. Datta. (1992). Pathogenic autoantibody-inducing T helper cells from patients with lupus nephritis express unusual T cell receptors. Clinical Immunology and Immunopathology. 62(3). 344–350. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stéphane Bécart Breakdown of academic impact, for papers by Paola Pittoni Breakdown of academic impact, for papers by S. M. Shahjahan Miah Breakdown of academic impact, for papers by Noriyasu Seki Breakdown of academic impact, for papers by Patricia Marchal Breakdown of academic impact, for papers by Dávid Győri Breakdown of academic impact, for papers by Alexander Martens Breakdown of academic impact, for papers by Tammy P. Cheng Breakdown of academic impact, for papers by Cyril Šálek Breakdown of academic impact, for papers by Xingwen Dong
Rankless by CCL
2026